Inheriting the lead after odds-on favorite and expected pacesetter Hot and Sultry broke awkwardly and got away last, Comparative experienced mild pressure from Shotgun Hottie entering the clubhouse ...
Endostar plus gemcitabine/cisplatin (GP) with maintenance endostar as first-line therapy for advanced non-small cell lung cancer (NSCLC): Preliminary results of a phase II study. This is an ASCO ...
Validation of time to treatment change (TTC) as a surrogate end-point of progression free survival (PFS) for observational trials in metastatic breast cancer patients (MBC): The GIM-13 AMBRA study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results